Globenewswire·2025-11-27 07:00Core Insights - Fangzhou Inc. and Tencent Healthcare have launched a comprehensive "AI+Chronic Disease Management" solution, marking a significant advancement in the application of AI in China's healthcare sector [1][6] - The solution integrates Fangzhou's AI+H2H ecosystem with Tencent Cloud's technological capabilities, aiming to enhance chronic disease management through intelligent service delivery [2][5] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, serving 52.8 million registered users and 229,000 physicians as of June 30, 2025 [9] - The company specializes in tailored medical care and AI-enabled precision medicine solutions [9] Strategic Collaboration - The partnership combines Fangzhou's expertise in healthcare with Tencent Healthcare's industrial-grade infrastructure, aiming to set a new standard for chronic disease management in China [3] - Tencent Healthcare provides a robust technological foundation, leveraging its capabilities in cloud computing, big data, and AI to support the transformation of chronic disease management [2][5] Technological Framework - The solution is built on Tencent Healthcare's TI platform, which enables continuous model optimization through one-stop training, evaluation, and deployment pipelines [5] - Tencent's vector database enhances the accuracy of medical knowledge retrieval, supporting the solution's compliance with regulatory standards for clinical AI [5] Compliance and Safety - Fangzhou emphasizes safety and compliance, implementing multiple layers of protection against AI hallucinations in clinical settings [4] - The partnership aligns with the National Health Commission's guidelines for developing safe "AI + healthcare" applications, supporting long-term national health goals under the "Healthy China 2030" initiative [6]